Why do we urgently need a new treatment for cerebral aspergillosis?: Expert Review of Anti-infective Therapy: Vol 0, No 0 - Get Access https://t.co/TShlpCLleZ
@airindia I could experience difference in travel before couple of years and now with Air India. It has improved. Hope AI will continue and maintain this great travel experiences in future.
🆕🔥Adjunctive corticosteroids in non-AIDS patients with severe Pneumocystis jirovecii pneumonia (PIC): a multicentre, double-blind, randomised controlled trial #IDXposts
https://t.co/e6Q9y8a3Zp
The #MMTN Conference is heading to #Indonesia on October 4–5, 2025 in Manado!
Expand your knowledge, connect with regional and global experts, and sharpen your skills in #medicalmycology.
Register before July 31 for the early-bird rate: https://t.co/hZJui6xUoy
#thinkfungus
🦠📊 Limited role of serum #galactomannan in diagnosing #COVID-19–associated pulmonary #aspergillosis (#CAPA), but shows #BAL galactomannan ≥1.01 is a strong diagnostic marker (81.3% sensitivity / 79.5% specificity)
Early diagnosis = better outcomes
https://t.co/3LhyS52C4C
Masterclass in Fungal infection at Kottayam, Kerala started by a Talk from Opening Batsman Dr. Arunaloke. #fisf#CIDS. Having delicious south india breakfast just before the master class.
I liked the proceedings of Mycology workshop at Kuala Lumpur. No rush for the presenters ample time for Q/A sessions and also for lunch. Audience was alert and engaging. Thank you Dr Low Lee Lee for inviting me to be a part of Mycology workshop 2025.